JonklaasJ, BiancoAC, BauerAJ, et al.Guidelines for the treatment of hypothyroidism: Prepared by the American thyroid association task force on thyroid hormone replacement. Thyroid, 2014; 24(12):1670–1751; doi: 10.1089/thy.2014.0028
2.
NexøMA, WattT, ClealB, et al.Exploring the experiences of people with hypo- and hyperthyroidism. Qual Health Res, 2015; 25(7):945–953; doi: 10.1177/1049732314554093
JonklaasJ. Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level. Curr Opin Endocrinol Diabetes Obes, 2017; 24(5):356–363; doi: 10.1097/MED.0000000000000355
5.
HegedüsL, BiancoAC, JonklaasJ, et al.Primary hypothyroidism and quality of life. Nat Rev Endocrinol, 2022; 18(4):230–242; doi: 10.1038/s41574-021-00625-8
6.
WongCK, LangBH, LamCL. A systematic review of quality of thyroid-specific health-related quality-of-life instruments recommends ThyPRO for patients with benign thyroid diseases. J Clin Epidemiol, 2016; 78:63–72; doi: 10.1016/j.jclinepi.2016.03.006
7.
WattT, HegedüsL, GroenvoldM, et al.Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol. 2010; 162(1):161–167; doi: 10.1530/EJE-09-0521
8.
WattT, CramonP, HegedüsL, et al.The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab, 2014; 99(10):3708–3717; doi: 10.1210/jc.2014-1322
9.
McMillanC, BradleyC, RazviS, et al.Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: The ThyDQoL and ThySRQ. Value Health, 2008; 11(2):285–294; doi: 10.1111/j.1524-4733.2007.00232.x
10.
McMillanCV, BradleyC, WoodcockA, et al.Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism. Thyroid, 2004; 14(11):916–925; doi: 10.1089/thy.2004.14.916
11.
PerrosP, HegedüsL, NagyEV, et al.The impact of hypothyroidism on satisfaction with care and treatment and everyday living: Results from E-Mode Patient self-Assessment of THYroid therapy (E-MPATHY), a cross sectional, international online patient survey. Thyroid, 2022 (in press); doi: 10.1089/thy.2022.0324
12.
WattT, BjornerJB, GroenvoldM, et al.Development of a short version of the thyroid-related patient-reported outcome ThyPRO. Thyroid, 2015; 25(10):1069–1079; doi: 10.1089/thy.2015.0209
13.
KroenkeK, SpitzerRL, WilliamsJB. The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med, 2002; 64(2):258–266; doi: 10.1097/00006842-200203000-00008
14.
DenolletJ. DS14: Standard assessment of negative affectivity, social inhibition, and type D personality. Psychosom Med, 2005; 67(1):89–97; doi: 10.1097/01.psy.0000149256.81953.49
15.
Picker Institute. The Picker Principles of Person Centred Care. n.d. Available from: https://picker.org/who-we-are/the-picker-principles-of-person-centred-care/ [Last accessed: August 23, 2022].
16.
PetersonSJ, CappolaAR, CastroMR, et al.An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid, 2018; 28(6):707–721; doi: 10.1089/thy.2017.0681
17.
MitchellAL, HegedüsL, ŽarkovićM, et al.Patient satisfaction and quality of life in hypothyroidism: An online survey by the British thyroid foundation. Clin Endocrinol (Oxf), 2020; 94(3):513–520; doi: 10.1111/cen.14340
18.
EttlesonMD, RaineA, BatistuzzoA, et al.Brain fog in hypothyroidism: Understanding the patient's perspective. Endocr Pract, 2022; 28(3):257–264; doi: 10.1016/j.eprac.2021.12.003
19.
ZhangY, CoelloPA, BrożekJ, et al.Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach. Health Qual Life Outcomes, 2017; 15(1):52; doi: 10.1186/s12955-017-0621-0
20.
MontoriVM, BritoJP, MuradMH. The optimal practice of evidence-based medicine: Incorporating patient preferences in practice guidelines. JAMA, 2013; 310(23):2503–2504; doi: 10.1001/jama.2013.281422
